144 related articles for article (PubMed ID: 30084576)
1. Bleeding Risk Assessment and the Role of Primary Hemostasis Screening in Patients Undergoing Kidney Biopsy.
Rottenstreich A; Schwartz A; Kalish Y; Shai E; Appelbaum L; Bdolah-Abram T; Sagiv I
Isr Med Assoc J; 2018 Aug; 20(8):499-503. PubMed ID: 30084576
[TBL] [Abstract][Full Text] [Related]
2. Thromboelastography versus bleeding time for risk of bleeding post native kidney biopsy.
Gal-Oz A; Papushado A; Kirgner I; Meirsdorf S; Schwartz D; Schwartz IF; Zubkov A; Grupper A
Ren Fail; 2020 Nov; 42(1):10-18. PubMed ID: 31842662
[No Abstract] [Full Text] [Related]
3. Bleeding complications after transcutaneous kidney biopsy in patients with systemic amyloidosis: single-center experience in 101 patients.
Soares SM; Fervenza FC; Lager DJ; Gertz MA; Cosio FG; Leung N
Am J Kidney Dis; 2008 Dec; 52(6):1079-83. PubMed ID: 18649980
[TBL] [Abstract][Full Text] [Related]
4. Perioperative monitoring of primary and secondary hemostasis in coronary artery bypass grafting.
Hertfelder HJ; Bös M; Weber D; Winkler K; Hanfland P; Preusse CJ
Semin Thromb Hemost; 2005; 31(4):426-40. PubMed ID: 16149021
[TBL] [Abstract][Full Text] [Related]
5. Outpatient percutaneous native renal biopsy: safety profile in a large monocentric cohort.
Roccatello D; Sciascia S; Rossi D; Naretto C; Bazzan M; Solfietti L; Baldovino S; Menegatti E
BMJ Open; 2017 Jun; 7(6):e015243. PubMed ID: 28637732
[TBL] [Abstract][Full Text] [Related]
6. Desmopressin and bleeding risk after percutaneous kidney biopsy.
Athavale A; Kulkarni H; Arslan CD; Hart P
BMC Nephrol; 2019 Nov; 20(1):413. PubMed ID: 31730448
[TBL] [Abstract][Full Text] [Related]
7. Do platelet function analyzer-100 testing results correlate with bleeding events after percutaneous renal biopsy?
Islam N; Fulop T; Zsom L; Miller E; Mire CD; Lebrun CJ; Schmidt DW
Clin Nephrol; 2010 Mar; 73(3):229-37. PubMed ID: 20178723
[TBL] [Abstract][Full Text] [Related]
8. Predictors of bleeding complications in percutaneous ultrasound-guided renal biopsy.
Manno C; Strippoli GF; Arnesano L; Bonifati C; Campobasso N; Gesualdo L; Schena FP
Kidney Int; 2004 Oct; 66(4):1570-7. PubMed ID: 15458453
[TBL] [Abstract][Full Text] [Related]
9. Estimation of risk for major bleeding in native kidney biopsies in patients with multiple risk factors.
Lim CC; Tan RY; Choo JCJ; Tan HZ; Mok I; Chin YM; Tan CS
Int Urol Nephrol; 2022 Feb; 54(2):343-348. PubMed ID: 33913059
[TBL] [Abstract][Full Text] [Related]
10. Total Thrombus-formation Analysis System Predicts Periprocedural Bleeding Events in Patients With Coronary Artery Disease Undergoing Percutaneous Coronary Intervention.
Oimatsu Y; Kaikita K; Ishii M; Mitsuse T; Ito M; Arima Y; Sueta D; Takahashi A; Iwashita S; Yamamoto E; Kojima S; Hokimoto S; Tsujita K
J Am Heart Assoc; 2017 Apr; 6(4):. PubMed ID: 28438734
[TBL] [Abstract][Full Text] [Related]
11. A nationwide survey on clinical practice patterns and bleeding complications of percutaneous native kidney biopsy in Japan.
Kawaguchi T; Nagasawsa T; Tsuruya K; Miura K; Katsuno T; Morikawa T; Ishikawa E; Ogura M; Matsumura H; Kurayama R; Matsumoto S; Marui Y; Hara S; Maruyama S; Narita I; Okada H; Ubara Y;
Clin Exp Nephrol; 2020 May; 24(5):389-401. PubMed ID: 32189101
[TBL] [Abstract][Full Text] [Related]
12. Safety of Percutaneous Ultrasound-Guided Kidney Biopsy in Patients with AA Amyloidosis.
Altindal M; Yildirim T; Turkmen E; Unal M; Boga I; Yilmaz R; Arici M; Altun B; Erdem Y
Nephron; 2015; 131(1):17-22. PubMed ID: 26227420
[TBL] [Abstract][Full Text] [Related]
13. Predictors of kidney biopsy complication among patients with systemic lupus erythematosus.
Chen TK; Estrella MM; Fine DM
Lupus; 2012 Jul; 21(8):848-54. PubMed ID: 22415926
[TBL] [Abstract][Full Text] [Related]
14. Timing of complications in percutaneous renal biopsy: what is the optimal period of observation?
Marwah DS; Korbet SM
Am J Kidney Dis; 1996 Jul; 28(1):47-52. PubMed ID: 8712221
[TBL] [Abstract][Full Text] [Related]
15. Ultrasonography as a predictor of overt bleeding after renal biopsy.
Ishikawa E; Nomura S; Hamaguchi T; Obe T; Inoue-Kiyohara M; Oosugi K; Katayama K; Ito M
Clin Exp Nephrol; 2009 Aug; 13(4):325-331. PubMed ID: 19381759
[TBL] [Abstract][Full Text] [Related]
16. Assessment of platelet function analyzer (PFA-100) in kidney transplant patients before renal allograft biopsy: a retrospective single-center analysis.
Ranghino A; Mella A; Borchiellini A; Nappo A; Manzione AM; Gallo E; Giovinazzo G; Fop F; Segoloni GP; Biancone L
Transplant Proc; 2014 Sep; 46(7):2259-62. PubMed ID: 25242765
[TBL] [Abstract][Full Text] [Related]
17. Safety of paediatric percutaneous native kidney biopsy and factors predicting bleeding complications.
Rianthavorn P; Kerr SJ; Chiengthong K
Nephrology (Carlton); 2014 Mar; 19(3):143-8. PubMed ID: 24313556
[TBL] [Abstract][Full Text] [Related]
18. Risk Factors for Severe Bleeding Complications in Percutaneous Renal Biopsy.
Xu DM; Chen M; Zhou FD; Zhao MH
Am J Med Sci; 2017 Mar; 353(3):230-235. PubMed ID: 28262208
[TBL] [Abstract][Full Text] [Related]
19. The impact of bleeding times on major complication rates after percutaneous real-time ultrasound-guided renal biopsies.
Stiles KP; Hill C; LeBrun CJ; Reinmuth B; Yuan CM; Abbott KC
J Nephrol; 2001; 14(4):275-9. PubMed ID: 11506250
[TBL] [Abstract][Full Text] [Related]
20. Is it necessary to stop antiplatelet agents before a native renal biopsy?
Mackinnon B; Fraser E; Simpson K; Fox JG; Geddes C
Nephrol Dial Transplant; 2008 Nov; 23(11):3566-70. PubMed ID: 18503099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
